Combining both creates a comprehensive strategy for long-term vitality and confidence
The reason non-response happens relates to how your body's peptide signaling pathways function at the genetic level
149 Get a free quote Contact us any time Contact Us Full Name Email Address Phone Number Your Message Thank you for contacting us
Key Takeaways Triple agonist mechanism: Retatrutide is the first medication to activate GIP, GLP-1, and glucagon receptors simultaneously GLP-1 component reduces appetite and slows gastric emptying, the core appetite suppression pathway GIP component improves insulin sensitivity and promotes favorable fat distribution Glucagon component increases energy expenditure through thermogenesis and promotes fat breakdown Weight loss: Phase 2 trials showed up to 24.2% weight loss at 48 weeks, compared to tirzepatide (~22%) and semaglutide (~15%) Investigational status: Not FDA-approved
Zapala L, Juszczak K, Adamczyk P, et al
GROW-H pairs CJC-1295 (No DAC) and Ipamorelin (5mg each) a GHRH analog plus a GHRP the classic amplify from two receptors stack
